(Q45866789)

17 December 2017

title

Emerging HDL-based therapies for atherothrombotic vascular disease (English)

1 reference

17 December 2017

author name string

Prediman K Shah

series ordinal

1

1 reference

17 December 2017

publication date

1 February 2007

1 reference

17 December 2017

Current treatment options in cardiovascular medicine

published in

1 reference

17 December 2017

volume

9

1 reference

17 December 2017

issue

1

1 reference

17 December 2017

page(s)

60-70

1 reference

17 December 2017

Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Potential reverse cholesterol transport in humans

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11936-007-0052-Z

Cardiovascular status of carriers of the apolipoprotein A-I(Milano) mutant: the Limone sul Garda study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-007-0052-Z

Effects of recombinant apolipoprotein A-I(Milano) on aortic atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-007-0052-Z

Cholesteryl ester transfer protein inhibitor (JTT-705) and the development of atherosclerosis in rabbits with severe hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-007-0052-Z

Evidence that high-density lipoprotein cholesterol is an independent predictor of acute platelet-dependent thrombus formation.

21 January 2018

1 reference

12 December 2020

Rimonabant: a cannabinoid receptor type 1 blocker for management of multiple cardiometabolic risk factors

1 reference

12 December 2020

HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway

1 reference

12 December 2020

Large versus small unilamellar vesicles mediate reverse cholesterol transport in vivo into two distinct hepatic metabolic pools. Implications for the treatment of atherosclerosis

1 reference

12 December 2020

PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis

1 reference

12 December 2020

Bone marrow transplantation shows superior atheroprotective effects of gene therapy with apolipoprotein A-I Milano compared with wild-type apolipoprotein A-I in hyperlipidemic mice

1 reference

12 December 2020

Increased cholesterol efflux potential of sera from ApoA-IMilano carriers and transgenic mice

1 reference

12 December 2020

High-dose recombinant apolipoprotein A-I(milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization

1 reference

12 December 2020

High density lipoprotein plasma fractions inhibit aortic fatty streaks in cholesterol-fed rabbits

1 reference

12 December 2020

High-density lipoprotein restores endothelial function in hypercholesterolemic men.

1 reference

12 December 2020

Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study

1 reference

12 December 2020

Effects of intravenous apolipoprotein A-I/phosphatidylcholine discs on LCAT, PLTP, and CETP in plasma and peripheral lymph in humans

1 reference

12 December 2020

Transcriptional repression of atherogenic inflammation: modulation by PPARdelta

1 reference

12 December 2020

1 reference

12 December 2020

Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing is coming, part I.

1 reference

12 December 2020

High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase

1 reference

12 December 2020

Effect of JTT-705 on cholesteryl ester transfer protein and plasma lipid levels in normolipidemic animals

1 reference

12 December 2020

Cholesterol mobilization and regression of atheroma in cholesterol-fed rabbits induced by large unilamellar vesicles

1 reference

12 December 2020

Intravenous Injection of Rabbit Apolipoprotein A-I Inhibits the Progression of Atherosclerosis in Cholesterol-Fed Rabbits

1 reference

12 December 2020

Effects of pioglitazone on lipoproteins, inflammatory markers, and adipokines in nondiabetic patients with metabolic syndrome

1 reference

12 December 2020

Apolipoprotein A-I mimetic peptides: potential role in atherosclerosis management

1 reference

12 December 2020

Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI.

1 reference

12 December 2020

HDL as a target in the treatment of atherosclerotic cardiovascular disease

1 reference

12 December 2020

Recombinant apolipoprotein A-I(Milano) infusion into rabbit carotid artery rapidly removes lipid from fatty streaks.

1 reference

12 December 2020

Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice

1 reference

12 December 2020

A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family

1 reference

12 December 2020

Synthetic LXR agonists increase LDL in CETP species

1 reference

12 December 2020

Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing is coming, part II.

1 reference

12 December 2020

Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans

1 reference

12 December 2020

Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C.

1 reference

12 December 2020

Nuclear receptors as potential targets for modulating reverse cholesterol transport

1 reference

12 December 2020

The role of high-density lipoprotein in inflammation

1 reference

12 December 2020

Molecular identification of high and low affinity receptors for nicotinic acid

1 reference

12 December 2020

Insights into the molecular mechanisms of plaque rupture and thrombosis.

1 reference

12 December 2020

Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins

1 reference

12 December 2020

Role of fibric acid derivatives in the management of risk factors for coronary heart disease

1 reference

12 December 2020

Effects of intravenous apolipoprotein A-I/phosphatidylcholine discs on paraoxonase and platelet-activating factor acetylhydrolase in human plasma and tissue fluid

1 reference

12 December 2020

Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits

1 reference

12 December 2020

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

1 reference

12 December 2020

Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit

1 reference

12 December 2020

Rapid reversal of endothelial dysfunction in hypercholesterolemic apolipoprotein E-null mice by recombinant apolipoprotein A-I(Milano)-phospholipid complex

1 reference

12 December 2020

Apolipoprotein A-I(Milano) and apolipoprotein A-I(Paris) exhibit an antioxidant activity distinct from that of wild-type apolipoprotein A-I.

1 reference

12 December 2020

Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretion.

1 reference

12 December 2020

Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapib

1 reference

12 December 2020

PPARs as Therapeutic Targets: Reverse Cardiology?

1 reference

12 December 2020

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

1 reference

12 December 2020

Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review

1 reference

12 December 2020

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

12 December 2020

Differential effects of apolipoprotein A-I-mimetic peptide on evolving and established atherosclerosis in apolipoprotein E-null mice.

1 reference

12 December 2020

Human apolipoprotein A-I and A-I mimetic peptides: potential for atherosclerosis reversal

1 reference

12 December 2020

Recombinant apolipoprotein A-IMilano dimer inhibits carotid intimal thickening induced by perivascular manipulation in rabbits

1 reference

12 December 2020

Intravenous apoA-I/lecithin discs increase pre-beta-HDL concentration in tissue fluid and stimulate reverse cholesterol transport in humans

1 reference

12 December 2020

The safety and immunogenicity of a CETP vaccine in healthy adults

1 reference

12 December 2020

Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus

1 reference

12 December 2020

Increasing high-density lipoprotein cholesterol in dyslipidemia by cholesteryl ester transfer protein inhibition: an update for clinicians

1 reference

12 December 2020

Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol

1 reference

12 December 2020

10.1007/S11936-007-0052-Z

Identifiers

DOI

1 reference

17 December 2017

Dimensions Publication ID

1043355901

0 references

1 reference

17 December 2017